Guidance

Antipsychotic medicines: licensed products, uses and side effects

Antipsychotic drugs available in the UK, their side effects and their effect on dementia patients.

Documents

Pharmacovigilance Working Party Public Assessment Report on neuroleptics and cardiac safety

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email webupdates@mhra.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance Working Party Public Assessment Report on antipsychotics and cerebrovascular accident

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format, please email webupdates@mhra.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

This guidance explains how antipsychotics work and the antipsychotics that are licensed for use in the UK. It also examines some main side effects of this type of medicine and including risks associated with the use of antipsychotics in elderly people with dementia.